These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26104925)

  • 1. Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses.
    Rosenthal DI; Fuller CD; Peters LJ; Thames HD
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):715-7. PubMed ID: 26104925
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radiation therapy for head and neck cancer].
    Mitsuhashi N; Akimoto T; Hayakawa K; Muramatsu H; Niibe H
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Jan; 61(1):10-6. PubMed ID: 11218740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of major radiation fractionation and chemotherapy trials for organ preservation therapy in locally advanced head and neck squamous cell carcinoma.
    Parsons JT; Greene BD
    Pract Radiat Oncol; 2015; 5(5):343-349. PubMed ID: 25920699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
    Chen AM; Vaughan A; Narayan S; Vijayakumar S
    Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head and neck cancer. Introduction.
    Brizel DM
    Semin Radiat Oncol; 2009 Jan; 19(1):1-2. PubMed ID: 19028338
    [No Abstract]   [Full Text] [Related]  

  • 7. In reply to Boon et al.
    Beitler JJ; Bentzen SM; Hall EJ
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):456-7. PubMed ID: 25636775
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered fractionation for head and neck cancer.
    Garden AS
    Oncology (Williston Park); 2001 Oct; 15(10):1326-32, 1334; discussion 1334, 1339-41. PubMed ID: 11702960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IAEA-ACC study: a commendable start.
    Corry J
    Lancet Oncol; 2010 Jun; 11(6):503-4. PubMed ID: 20522372
    [No Abstract]   [Full Text] [Related]  

  • 10. [Better tumor control by simultaneous radiochemotherapy in advanced head-neck carcinomas].
    Wendt TG
    Strahlenther Onkol; 1999 Sep; 175(9):473-4. PubMed ID: 10518984
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck.
    Haffty BG; Son YH; Wilson LD; Papac R; Fischer D; Rockwell S; Sartorelli AC; Ross D; Sasaki CT; Fischer JJ
    Radiat Oncol Investig; 1997; 5(5):235-45. PubMed ID: 9372546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality assurance of radiation therapy for head and neck cancer patients treated in DAHANCA 10 randomized trial.
    Hansen CR; Johansen J; Kristensen CA; Smulders B; Andersen LJ; Samsøe E; Andersen E; Petersen JB; Overgaard J; Grau C
    Acta Oncol; 2015; 54(9):1669-73. PubMed ID: 26206516
    [No Abstract]   [Full Text] [Related]  

  • 13. Is 5-year feeding tube dependency a mixed consequential late effect? In regard to Beitler et al.
    Boon C; Meade S; Benghiat H; Sanghera P; Hartley A
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):455-6. PubMed ID: 25636774
    [No Abstract]   [Full Text] [Related]  

  • 14. Postoperative radiation therapy for squamous cell carcinoma of the head and neck.
    Mendenhall WM; Amdur RJ; Hinerman RW; Villaret DB; Siemann DW
    Am J Otolaryngol; 2003; 24(1):41-50. PubMed ID: 12579482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
    Rosenthal DI; Ang KK
    Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the future from trials of the past: epidermal growth factor receptor expression and outcome of fractionated radiation therapy trials.
    Dicker AP; Rodeck U
    J Clin Oncol; 2005 Aug; 23(24):5437-9. PubMed ID: 16110005
    [No Abstract]   [Full Text] [Related]  

  • 17. Cetuximab plus radiotherapy for head and neck cancer.
    Armstrong JG
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710907
    [No Abstract]   [Full Text] [Related]  

  • 18. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck.
    Mendenhall WM; Riggs CE; Amdur RJ; Hinerman RW; Villaret DB
    Laryngoscope; 2003 Mar; 113(3):546-51. PubMed ID: 12616212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
    Overgaard J; Mohanti BK; Begum N; Ali R; Agarwal JP; Kuddu M; Bhasker S; Tatsuzaki H; Grau C
    Lancet Oncol; 2010 Jun; 11(6):553-60. PubMed ID: 20382075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab plus radiotherapy for head and neck cancer.
    Cengiz M; Yildiz F; Genc M
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.